U.S., Nov. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07948031) titled 'Lumateperone Monotherapy Versus Usual Antidepressant Treatment for First-Episode Depression' on Nov. 13.

Brief Summary: This study will compare lumateperone monotherapy with usual antidepressant treatment in adults experiencing their first lifetime episode of major depressive disorder. Use of lumateperone alone for this form of depression is investigational.

The study will enroll 134 adults aged 18 to 65 years who have clinically significant depression and have not received medication to treat their current depressive episode. Participants will be assigned by chance to one of two groups. One group will receive lumateperone 42 mg on...